Oculis Holding AG Warrants
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-opht… Read more
Oculis Holding AG Warrants (OCSAW) - Total Liabilities
Latest total liabilities as of June 2024: $25.91 Million USD
Based on the latest financial reports, Oculis Holding AG Warrants (OCSAW) has total liabilities worth $25.91 Million USD as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Oculis Holding AG Warrants - Total Liabilities Trend (2020–2023)
This chart illustrates how Oculis Holding AG Warrants's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Oculis Holding AG Warrants Competitors by Total Liabilities
The table below lists competitors of Oculis Holding AG Warrants ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MSC Income Fund, Inc.
PINK:MSCF
|
USA | $608.80 Million |
|
Workforce Holdings Ltd
JSE:WKF
|
South Africa | ZAC684.65 Million |
|
Mahube Infrastructure Ltd
JSE:MHB
|
South Africa | ZAC1.13 Million |
|
Matvareexpressen As
OL:MVE
|
Norway | Nkr132.47 Million |
Liability Composition Analysis (2020–2023)
This chart breaks down Oculis Holding AG Warrants's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oculis Holding AG Warrants's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oculis Holding AG Warrants (2020–2023)
The table below shows the annual total liabilities of Oculis Holding AG Warrants from 2020 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $20.62 Million | -84.73% |
| 2022-12-31 | $135.05 Million | +13.49% |
| 2021-12-31 | $119.00 Million | +98.21% |
| 2020-12-31 | $60.04 Million | -- |